Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

Overview of attention for article published in BMC Cancer, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 191,311 followers.

RT @GordanLauc: @CarolynBertozzi @InterVennBioSci Very cool study! We published something similar recently. Glycans are a great patient-st…

08 Aug 2023

Reply Repost Favourite

RT @GordanLauc: @CarolynBertozzi @InterVennBioSci Very cool study! We published something similar recently. Glycans are a great patient-st…

25 Jul 2023

Reply Repost Favourite

@CarolynBertozzi @InterVennBioSci Very cool study! We published something similar recently. Glycans are a great patient-stratification tool, in particular in diseases that have something to do with our immune system. https://t.co/BzU4xifyIm

14 Jun 2023

Reply Repost Favourite

Study shows that serum N-glycans may be used as biomarkers of response to ICIs, allowing dicovery of new ways for stratifying patients and design of improved adjunct therapies. #melanoma #BMCCancer @MarioFalchi https://t.co/KxUbCgjviV https://t.co/hi496gj

04 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.